Subscribe to Newsletter

December 2021 Issue of The Medicine Maker

Join us as we celebrate the drug development and manufacturing technologies that have made waves in 2021 via our annual Innovation Awards! Congratulations to all our winners! Also in this issue, we delve into all things advanced medicine – covering the ins and out of adoptive cell therapies, as well as the key milestone the filed has achieved this year. In Business, we ask how a CDMO can balance its social responsibilities to the environment with its business objectives of supporting pharma, and in In My View, experts discuss a variety of areas including organ-on-a-chip, patient samples, and oncolytic viruses. Finally, we sit down with Jason Foster who shares a snapshot of his career in pharma.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Business & Regulation Business Practice

‘Tis the Season for… Awards

| Angus Stewart

Award season is here! Submit your nominations for the Power List and send in your votes for the Company of the Year Awards!
Manufacture Ingredients

Blue Light for Waste Reduction

| Angus Stewart

A team at the University of Bath have found a more efficient way to produce drugs using a catalyst powered by 420 nanometer blue light.
Discovery & Development Dosage Forms

Gilead Goes Ferreting

| Angus Stewart

A partnership between Gilead Sciences and Georgia State University has tested a new oral antiviral for COVID-19.
Discovery & Development COVID-19

Corporate Medicine, Government X-Rays

| Angus Stewart

Pfizer’s trial of a new medicine for COVID-19, produced with support from the US Department of Energy, could improve access to treatment.
Discovery & Development Formulation

The Digital Future of Formulation

| Ferdinand-Paul Brandl

Integrating digital technologies into your operations can make all the difference to the formulation process.
Discovery & Development Technology and Equipment

Reduce, Refine... Replace?

| Tomasz Kostrzewski

Adoption of organ-on-a-chip technology is on the rise, but misconceptions remain prevalent, says Tomasz Kostrzewski of CN Bio.
Discovery & Development Clinical Trials

Please, Sir, May I Have Some Samples?

| Robert Hewitt

Biotech companies need good patient samples, but hospitals are not always obliging...
Manufacture Bioprocessing - Upstream & Downstream

A New Focus for Cancer Therapeutics

| Joe Sinclair

Joe Sinclair gives his view on how to be successful with oncolytic virotherapy.

Manufacture Bioprocessing - Upstream & Downstream

Keep Calm and Use Pools

| Trent Munro

How pooled cell populations helped accelerate COVID-19 vaccine development – and what that means for the therapeutics of the future.
Manufacture Technology and Equipment

The Innovation Awards 2021

It’s time to celebrate The Medicine Maker annual Innovation Awards! Here, we showcase the top technologies released during 2021.
Manufacture Technology and Equipment

The Innovators

Meet two companies that are advancing pharmaceutical development and manufacture.
Manufacture Advanced Medicine

The Four Most Promising Adoptive Cell Therapies

| Marwan Alsarraj

A whistle-stop tour of the mechanisms, benefits, manufacturing challenges, and clinical potential of CAR T cells, TCR T cells, TILs, and NK cells.
Discovery & Development Ingredients

Natural Born Therapeutics

| Angus Stewart

Researchers at Trinity College Dublin explain how they are reaching into the natural environment to source new bioactives.
Manufacture Technology and Equipment

The Cobalt-60 Pioneers

| Sponsored by Nordion

Richard Wiens explains the importance of Cobalt-60 in the pharma industry – and why Nordion is a key player in the field
Business & Regulation Contract Manufacturing Services

The New CDMO on the Block

| Stephanie Vine

Can ten23 health really make a difference to the planet while fully supporting its biopharma customers? We find out.
Business & Regulation Profession

Scaling Advanced Therapies

| Angus Stewart

Meet Ori Biotech’s Jason Foster. How did he transition to advanced therapy, and why did he end up in the UK?

Other issues of 2021